Nexo Therapeutics, Inc.

CIK 1955319 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nexo Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 27, 2026D/A0001955319-26-000001
Sep 17, 2025D/A0001955319-25-000002
Sep 13, 2024D/A0001955319-24-000001
Nov 21, 2022D0001955319-22-000002